Many researchers have demonstrated that YKL-40 levels are elevated in many inflammatory diseases, for instance, rhinitis, asthma, tumors, myelofibrosis, and chronic obstructive pulmonary disease (COPD). This evidence concerns the gene CHI3L1 and chronic obstructive pulmonary disease.